Brian Bloom
CEOMale0.0Global Dominance: 0.00%
Brian Bloom is the CEO of Bloom Burton & Co., a leading life sciences underwriter in Canada. He is recognized for his insights into the biotechnology industry and has praised Francesco Bellini's achievements, particularly highlighting the monumental sale of BioChem Pharma as a benchmark in the biopharmaceutical field.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Brian Bloom, chief executive officer of Bloom Burton & Co., commented on Zymeworks needing partner capital for the Theravance deal.
Zymeworks offers US$929-million for COPD drug maker TheravanceThe Globe and Mail·
Canada· 2026-06-30
Canada· 2026-06-30
In 2001, Dr. Bellini sold BioChem for $5.9-billion in a transaction that set the bar for the industry.
Biotech entrepreneur Francesco Bellini uplifted the next generation of Canadian scientistsThe Globe and Mail·Canada· 2025-07-14
Canada· 2025-07-14
